{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:12:46Z","timestamp":1791202366932,"version":"4.2.0"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T00:00:00Z","timestamp":1369094400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0064221","type":"journal-article","created":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T21:24:17Z","timestamp":1369171457000},"page":"e64221","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":67,"title":["A Novel Monoclonal Anti-CD81 Antibody Produced by Genetic Immunization Efficiently Inhibits Hepatitis C Virus Cell-Cell Transmission"],"prefix":"10.1371","volume":"8","author":[{"given":"Isabel","family":"Fofana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Thumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Turek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Zona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv G.","family":"Tawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz","family":"Grunert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam B.","family":"Zeisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Baumert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,5,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1053\/j.gastro.2009.11.055","article-title":"Resistance to direct antiviral agents in patients with hepatitis C virus infection","volume":"138","author":"C Sarrazin","year":"2010","journal-title":"Gastroenterology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature04083","article-title":"Hepatitis C and liver transplantation","volume":"436","author":"RS Brown","year":"2005","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/j.1600-6143.2009.02702.x","article-title":"A practical guide to the management of HCV infection following liver transplantation","volume":"9","author":"K Watt","year":"2009","journal-title":"Am J Transplant"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1053\/j.gastro.2012.02.011","article-title":"Viral hepatitis in liver transplantation","volume":"142","author":"G Crespo","year":"2012","journal-title":"Gastroenterology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/hep.24470","article-title":"Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents\u2013a potentially lethal cocktail","volume":"54","author":"M Charlton","year":"2011","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jhep.2010.10.014","article-title":"Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies","volume":"54","author":"MB Zeisel","year":"2011","journal-title":"J Hepatol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jhep.2012.09.022","article-title":"Host-targeting agents for prevention and treatment of chronic hepatitis C - perspectives and challenges","volume":"58","author":"MB Zeisel","year":"2013","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1084\/jem.20090766","article-title":"Enhanced viral entry and escape from antibody-mediated neutralization are key determinants for hepatitis C virus re-infection in liver transplantation","volume":"207","author":"S Fafi-Kremer","year":"2010","journal-title":"J Exp Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1053\/j.gastro.2010.05.073","article-title":"Monoclonal anti-claudin 1 antibodies for prevention of hepatitis C virus infection","volume":"139","author":"I Fofana","year":"2010","journal-title":"Gastroenterology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/hep.21959","article-title":"Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies","volume":"47","author":"JM Timpe","year":"2008","journal-title":"Hepatology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"P Pileri","year":"1998","journal-title":"Science"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1126\/science.1114016","article-title":"Complete replication of hepatitis C virus in cell culture","volume":"309","author":"BD Lindenbach","year":"2005","journal-title":"Science"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"11331","DOI":"10.1128\/JVI.00104-06","article-title":"Diverse CD81 proteins support hepatitis C virus infection","volume":"80","author":"M Flint","year":"2006","journal-title":"J Virol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"41624","DOI":"10.1074\/jbc.M305289200","article-title":"Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor","volume":"278","author":"B Bartosch","year":"2003","journal-title":"J Biol Chem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1128\/JVI.78.3.1448-1455.2004","article-title":"CD81 is required for hepatitis C virus glycoprotein-mediated viral infection","volume":"78","author":"J Zhang","year":"2004","journal-title":"J Virol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1128\/JVI.01534-06","article-title":"The level of CD81 cell surface expression is a key determinant for productive entry of Hepatitis C Virus into host cells","volume":"81","author":"G Koutsoudakis","year":"2007","journal-title":"J Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1128\/JVI.01573-06","article-title":"CD81 expression is important for heterogeneous HCV permissiveness of Huh7 cell clones","volume":"81","author":"D Akazawa","year":"2007","journal-title":"J Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1128\/JVI.02460-05","article-title":"Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses","volume":"80","author":"G Koutsoudakis","year":"2006","journal-title":"J Virol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nature05654","article-title":"Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry","volume":"446","author":"MJ Evans","year":"2007","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1128\/JVI.06996-11","article-title":"Hepatitis C virus induces CD81 and claudin-1 endocytosis","volume":"86","author":"MJ Farquhar","year":"2012","journal-title":"J Virol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1128\/JVI.02286-07","article-title":"CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry","volume":"82","author":"HJ Harris","year":"2008","journal-title":"J Virol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"21092","DOI":"10.1074\/jbc.M110.104836","article-title":"Claudin association with CD81 defines hepatitis C virus entry","volume":"285","author":"HJ Harris","year":"2010","journal-title":"J Biol Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.1128\/JVI.00592-08","article-title":"Protein kinase A-dependent step(s) in hepatitis C virus entry and infectivity","volume":"82","author":"MJ Farquhar","year":"2008","journal-title":"J Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.23445","article-title":"Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations","volume":"51","author":"SE Krieger","year":"2010","journal-title":"Hepatology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm.2341","article-title":"EGFR and EphA2 are hepatitis C virus host entry factors and targets for antiviral therapy","volume":"17","author":"J Lupberger","year":"2011","journal-title":"Nat Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/nature07684","article-title":"Human occludin is a hepatitis C virus entry factor required for infection of mouse cells","volume":"457","author":"A Ploss","year":"2009","journal-title":"Nature"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nature10168","article-title":"A genetically humanized mouse model for hepatitis C virus infection","volume":"474","author":"M Dorner","year":"2011","journal-title":"Nature"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e1000978","DOI":"10.1371\/journal.ppat.1000978","article-title":"Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors","volume":"6","author":"J Bitzegeio","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/hep.22547","article-title":"Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo","volume":"48","author":"P Meuleman","year":"2008","journal-title":"Hepatology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome","volume":"11","author":"T Wakita","year":"2005","journal-title":"Nat Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"9294","DOI":"10.1073\/pnas.0503596102","article-title":"Robust hepatitis C virus infection in vitro","volume":"102","author":"J Zhong","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/JVI.01592-10","article-title":"Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission","volume":"85","author":"CL Brimacombe","year":"2011","journal-title":"J Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nm.2581","article-title":"Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor","volume":"18","author":"B Sainz Jr","year":"2012","journal-title":"Nat Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1099\/vir.0.006700-0","article-title":"CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells","volume":"90","author":"J Witteveldt","year":"2009","journal-title":"J Gen Virol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nbt.1604","article-title":"Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system","volume":"28","author":"CT Jones","year":"2010","journal-title":"Nat Biotechnol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1073\/pnas.0607026104","article-title":"Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C","volume":"104","author":"JM Pestka","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.1128\/JVI.00246-09","article-title":"Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells","volume":"83","author":"CJ Mee","year":"2009","journal-title":"J Virol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/hep.26097","article-title":"The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination","volume":"57","author":"MN Zahid","year":"2013","journal-title":"Hepatology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1053\/j.gastro.2008.07.018","article-title":"Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion","volume":"135","author":"A Haberstroh","year":"2008","journal-title":"Gastroenterology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"11919","DOI":"10.1128\/JVI.01066-12","article-title":"Reconstitution of the entire hepatitis C virus life cycle in nonhepatic cells","volume":"86","author":"D Da Costa","year":"2012","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20021756","article-title":"Infectious hepatitis C virus pseudo-particles containing functional E1\u2013E2 envelope protein complexes","volume":"197","author":"B Bartosch","year":"2003","journal-title":"J Exp Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/infdis\/jir802","article-title":"Evaluation of ITX 5061, a scavenger receptor B1 antagonist: resistance selection and activity in combination with other hepatitis C virus antivirals","volume":"205","author":"H Zhu","year":"2012","journal-title":"J Infect Dis"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"7994","DOI":"10.1158\/1078-0432.CCR-04-1087","article-title":"Evaluation of combination chemotherapy: integration of nonlinear regression, curve shift, isobologram, and combination index analyses","volume":"10","author":"L Zhao","year":"2004","journal-title":"Clin Cancer Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.1128\/JVI.80.10.4940-4948.2006","article-title":"Different domains of CD81 mediate distinct stages of hepatitis C virus pseudoparticle entry","volume":"80","author":"C Bertaux","year":"2006","journal-title":"J Virol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/hep.21994","article-title":"Scavenger receptor BI is a key host factor for Hepatitis C virus infection required for an entry step closely linked to CD81","volume":"46","author":"MB Zeisel","year":"2007","journal-title":"Hepatology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/j.gastro.2012.04.006","article-title":"Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodies","volume":"143","author":"I Fofana","year":"2012","journal-title":"Gastroenterology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"14626","DOI":"10.1073\/pnas.94.26.14626","article-title":"DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity","volume":"94","author":"JS Boyle","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1128\/JVI.73.8.6235-6244.1999","article-title":"Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor CD81","volume":"73","author":"M Flint","year":"1999","journal-title":"J Virol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1099\/0022-1317-82-8-1877","article-title":"Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2","volume":"82","author":"A Owsianka","year":"2001","journal-title":"J Gen Virol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1099\/0022-1317-81-12-2873","article-title":"Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding","volume":"81","author":"AH Patel","year":"2000","journal-title":"J Gen Virol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"12407","DOI":"10.1128\/JVI.01552-09","article-title":"Hepatoma cell density promotes claudin-1 and scavenger receptor BI expression and hepatitis C virus internalization","volume":"83","author":"AK Schwarz","year":"2009","journal-title":"J Virol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/hep.24692","article-title":"A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo","volume":"55","author":"P Meuleman","year":"2012","journal-title":"Hepatology"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jhep.2012.02.018","article-title":"Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice","volume":"57","author":"K Lacek","year":"2012","journal-title":"J Hepatol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0064221","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:16:26Z","timestamp":1595808986000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0064221"}},"subtitle":[],"editor":[{"given":"Stephen J.","family":"Polyak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,5,21]]},"references-count":53,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,5,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0064221","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,21]]}}}